My areas of interest include basic and translational research on traumatic brain injury, ischemic stroke, neuroprotection, neurosteroids, brain injury repair and recovery, blood-based biomarkers of brain injury.
Dr. Sayeed joined the scientific review branch (SRB) at the National Institute of Neurological Disorders and Stroke (NINDS) in November of 2022. As a scientific review officer at NINDS, Dr. Sayeed will lead the scientific merit review of proposals in special emphasis panels and study sections run within the clinical cluster of the Scientific Reveiw Board. Dr. Sayeed received his Ph.D. in Toxicology from Hamdard University (New Delhi, India) and is a Diplomate of American Board of Toxicology. Prior to joining NIH, Dr. Sayeed was associate professor in the Department of Emergency Medicine at Emory University. His laboratory research focused on the molecular mechanism of neurosteroids in CNS injury and examined potential use of progesterone and its analogs across developmental stages, studying neonatal and aged models of traumatic brain injury and ischemic stroke with associated comorbidities. His recent NIH/NINDS funded component of research program focused on the development and validation of blood-based and physiological biomarkers of TBI. Finding from these studies identified Osteopontin as a blood biomarker for the severity and outcomes of pediatric TBI having important translational implications for populations at risk for head injuries. Dr. Sayeed transitioned into career at NIH to advance the mission of NINDS and is looking forward to using his expertise to make preclinical biomedical research translationally meaningful and successful.